Phyton Biotech is the largest single supplier of Paclitaxel in the world, producing the API-grade product using our proprietary “green” Plant Cell Fermentation (PCF®) Technology. Our Paclitaxel is made from 100% natural plant sources and is GMO-free.
Phyton Biotech is the world’s only large-scale supplier that produces Docetaxel API without relying on plantation-derived extracts from yew trees, which are vulnerable to harvesting and supply issues. Phyton is also the only Docetaxel supplier in the world that controls the entire upstream and downstream production process internally under strict cGMP conditions.
Phyton Biotech has transformed plant cell culture techniques practised for decades into a truly scalable, reproducible and proprietary “green” technology for the development and commercialization of high-value phytochemicals. Our patented Plant Cell Fermentation (PCF®) Technology offers superior supply solutions, overcoming limitations and drawbacks often experienced with traditional plant extraction and chemical synthesis.
Phyton Biotech offers clients a full range of integrated contract product and process development and commercial manufacturing services across the entire development chain, from feasibility to commercial production.
Phyton is the largest single supplier of Paclitaxel in the world, producing the API-grade product using our proprietary “green” Plant Cell Fermentation (PCF®) Technology. Our Paclitaxel is made from 100% natural plant sources and is GMO-free.
Phyton Biotech is the world’s only large-scale supplier that produces Docetaxel API without relying on plantation-derived extracts from yew trees, which are vulnerable to harvesting and supply issues. Phyton is also the only Docetaxel supplier in the world that controls the entire upstream and downstream production process internally under strict cGMP conditions.
Phyton Biotech has transformed plant cell culture techniques practised for decades into a truly scalable, reproducible and proprietary “green” technology for the development and commercialization of high-value phytochemicals. Our patented Plant Cell Fermentation PCF® Technology offers superior supply solutions, overcoming limitations and drawbacks often experienced with traditional plant extraction and chemical synthesis.
Phyton Biotech offers clients a full range of integrated contract product and process development and commercial manufacturing services across the entire development chain, from feasibility to commercial production.
Plant Cell Fermentation (PCF®) Technology
Leveraging our award-winning PCF® Technology, Phyton Biotech is now the world’s largest producer of taxane APIs and possesses the capacity to meet over one-third of the world’s demand for Paclitaxel and Docetaxel API.
Award-winning, environmentally responsible biotechnology for development of phytochemicals at commercial scale across various industries
Proprietary library of hundreds of plant cell cultures of vascular and non-vascular plants accessible for your development project
Strictly controlled GMP-compliant supply and production processes enable tight product consistency and quality in accordance with regulatory standards
A sustainable solution able to overcome supply constraints for actives derived from rare, hard-to-source, slow-growing or endangered plant species
Scalable, cost-competitive industrial production from kgs to tonnes of annual product volumes
World’s largest producer of Paclitaxel and Docetaxel via PCF®
Award-winning “green” chemistry
World’s largest commercial plant cell fermentation CDMO
Latest News
Latest News
Phyton Biotech Unifies International Operations Under New Leadership
DFB Pharmaceuticals, a Fort Worth, Texas-based private investment group with an entrepreneurial drive for developing new products and businesses in healthcare, announced the promotion of Colin Marr to President of Phyton Ltd.
Latest Events
Phyton Biotech joins pharmaceutical leaders at CPhI Worldwide in Madrid
As global leaders in plant cell fermentation, Phyton Biotech is pleased to announce our participation at CPhI Worldwide in Madrid, Spain from October 9-11, 2018.
Latest Case Study
Case Study: Green Chemistry
Taxol® (manufactured by Bristol-Myers Squibb) is an important drug used to treat many types of solid tumor cancers and Kaposi’s sarcoma. It is on the World Health Organization’s List of Essential Medicines, the most needed medicines in a health care system.